Loading...
Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation
Wei, Bingchuan ; Gao, Xuan ; Cadang, Lance ; Izadi, Saeed ; Liu, Peilu ; Zhang, Hui-Min ; Hecht, Elizabeth ; Shim, Jeongsup ; Magill, Gordon ; Pabon, Juan Rincon ... show 10 more
Wei, Bingchuan
Gao, Xuan
Cadang, Lance
Izadi, Saeed
Liu, Peilu
Zhang, Hui-Min
Hecht, Elizabeth
Shim, Jeongsup
Magill, Gordon
Pabon, Juan Rincon
Citations
Altmetric:
Abstract
Fc galactosylation is a critical quality attribute for anti-tumor recombinant immunoglobulin G (IgG)-based monoclonal antibody (mAb) therapeutics with complement-dependent cytotoxicity (CDC) as the mechanism of action. Although the correlation between galactosylation and CDC has been known, the underlying structure–function relationship is unclear. Heterogeneity of the Fc N-glycosylation produced by Chinese hamster ovary (CHO) cell culture biomanufacturing process leads to variable CDC potency. Here, we derived a kinetic model of galactose transfer reaction in the Golgi apparatus and used this model to determine the correlation between differently galactosylated species from CHO cell culture process. The model was validated by a retrospective data analysis of more than 800 historical samples from small-scale and large-scale CHO cell cultures. Furthermore, using various analytical technologies, we discovered the molecular basis for Fc glycan terminal galactosylation changing the three-dimensional conformation of the Fc, which facilitates the IgG1 hexamerization, thus enhancing C1q avidity and subsequent complement activation. Our study offers insight into the formation of galactosylated species, as well as a novel three-dimensional understanding of the structure–function relationship of terminal galactose to complement activation in mAb therapeutics.
Description
Date
2021-03-08
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis Open Access
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Monoclona antibody; IgG1, Galactosylation, CDC; CHO Cell Culture, CQA; mass Spectrometry, Kinetics
Citation
Wei, B., Gao, X., Cadang, L., Izadi, S., Liu, P., Zhang, H. M., Hecht, E., Shim, J., Magill, G., Pabon, J. R., Dai, L., Phung, W., Lin, E., Wang, C., Whang, K., Sanchez, S., Oropeza, J., Jr, Camperi, J., Zhang, J., Sandoval, W., … Jiang, G. (2021). Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation. mAbs, 13(1), 1893427. https://doi.org/10.1080/19420862.2021.1893427